COMMONWEALTH EQUITY SERVICES, LLC

Position in VYGR — Voyager Therapeutics, Inc.

CIK 312272 WALTHAM, MA

Position in VYGR

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$40,964

-$2,669 QoQ

Shares Held

11,704

+3.5% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 135 holders

Holding Since

Jun 2022

14 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. VYGR ranks #98 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,964	11,704	+3.5%	Shares	Sole	2026-07-29
2026-03-31	$43,633	11,304	+0.4%	Shares	Sole	2026-04-27
2025-12-31	$44,228	11,254	-31.7%	Shares	Sole	2026-02-12
2025-09-30	$76,947	16,477	-54.2%	Shares	Sole	2025-10-22
2025-06-30	$111,804	35,950	-46.6%	Shares	Sole	2025-08-06
2025-03-31	$227,555	67,324	+2.0%	Shares	Sole	2025-05-09
2024-12-31	$374,390	66,030	-4.2%	Shares	Sole	2025-02-10
2024-09-30	$403,240	68,930	-11.5%	Shares	Sole	2024-10-18
2024-06-30	$616,228	77,905	+36.8%	Shares	Sole	2024-07-31
2024-03-31	$530,251	56,955	+216.4%	Shares	Sole	2024-04-29
2023-03-31	$138,780	18,000	-23.4%	Shares	Sole	2023-05-11
2022-12-31	$143,350	23,500	-3.4%	Shares	Sole	2023-02-07
2022-09-30	$144,057	24,334	0.0%	Shares	Sole	2022-11-14
2022-06-30	$143,813	24,334	—	Shares	Sole	2022-07-19
No filing history on record for this holder in this stock.